Octavia Wealth Advisors LLC acquired a new stake in UiPath Inc. (NYSE:PATH – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,321 shares of the healthcare company’s stock, valued at approximately $132,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Future Financial Wealth Managment LLC bought a new stake in UiPath during the third quarter valued at about $26,000. ORG Partners LLC grew its holdings in UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the last quarter. Hantz Financial Services Inc. bought a new position in UiPath in the 2nd quarter worth approximately $28,000. Redwood Wealth Management Group LLC acquired a new position in shares of UiPath during the second quarter worth approximately $43,000. Finally, GAMMA Investing LLC boosted its position in shares of UiPath by 40.2% in the first quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after acquiring an additional 632 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
PATH has been the subject of several research analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and set a $16.00 target price on shares of UiPath in a research note on Friday, September 6th. Bank of America increased their target price on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. BMO Capital Markets boosted their price target on UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a research note on Friday, September 6th. Barclays raised their price objective on UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of UiPath in a research report on Friday, September 6th. Sixteen analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $17.71.
Insider Transactions at UiPath
In related news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the sale, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 22.37% of the stock is owned by company insiders.
UiPath Price Performance
NYSE PATH opened at $12.70 on Friday. The stock’s 50 day simple moving average is $12.22 and its 200 day simple moving average is $14.74. UiPath Inc. has a one year low of $10.37 and a one year high of $27.87. The firm has a market cap of $7.27 billion, a PE ratio of -79.38 and a beta of 0.88.
UiPath (NYSE:PATH – Get Free Report) last announced its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the company posted ($0.09) earnings per share. As a group, equities analysts expect that UiPath Inc. will post -0.23 earnings per share for the current year.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
- Five stocks we like better than UiPath
- What Are Dividend Champions? How to Invest in the Champions
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- What is a support level?
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 10/7 – 10/11
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.